Электронный архив

Просмотр по автору "Heery D."

Просмотр по автору "Heery D."

Отсортировать по:Сортировать:Результаты поиска на странице:

  • Androgen dependent mechanisms of pro-angiogenic networks in placental and tumor development 
    Metzler V.; de Brot S.; Robinson R.; Jeyapalan J.; Rakha E.; Walton T.; Gardner D.; Lund E.; Whitchurch J.; Haigh D.; Lochray J.; Robinson B.; Allegrucci C.; Fray R.; Persson J.; Ødum N.; Miftakhova R.; Rizvanov A.; Hughes I.; Tadokoro-Cuccaro R.; Heery D.; Rutland C.; Mongan N. (2017)
    © 2017 Elsevier Ltd The placenta and tumors share important characteristics, including a requirement to establish effective angiogenesis. In the case of the placenta, optimal angiogenesis is required to sustain the blood ...
  • Androgen dependent mechanisms of pro-angiogenic networks in placental and tumor development 
    Metzler V.; de Brot S.; Robinson R.; Jeyapalan J.; Rakha E.; Walton T.; Gardner D.; Lund E.; Whitchurch J.; Haigh D.; Lochray J.; Robinson B.; Allegrucci C.; Fray R.; Persson J.; Ødum N.; Miftakhova R.; Rizvanov A.; Hughes I.; Tadokoro-Cuccaro R.; Heery D.; Rutland C.; Mongan N. (2016)
    © 2017 Elsevier Ltd.The placenta and tumors share important characteristics, including a requirement to establish effective angiogenesis. In the case of the placenta, optimal angiogenesis is required to sustain the blood ...
  • Cyclin A1 and P450 aromatase promote metastatic homing and growth of stem-like prostate cancer cells in the bone marrow 
    Miftakhova R.; Hedblom A.; Semenas J.; Robinson B.; Simoulis A.; Malm J.; Rizvanov A.; Heery D.; Mongan N.; Maitland N.; Allegrucci C.; Persson J. (2016)
    © 2016 American Association for Cancer Research.Bone metastasis is a leading cause ofmorbidity andmortality in prostate cancer.While cancer stem-like cells have been implicated as a cell of origin for prostate cancer ...
  • Targeted suppression of AR-V7 using PIP5K1α inhibitor overcomes enzalutamide resistance in prostate cancer cells 
    Sarwar M.; Semenas J.; Miftakhova R.; Simoulis A.; Robinson B.; Wingren A.; Mongan N.; Heery D.; Johnsson H.; Abrahamsson P.; Dizeyi N.; Luo J.; Persson J. (2016)
    One mechanism of resistance of prostate cancer (PCa) to enzalutamide (MDV3100) treatment is the increased expression of AR variants lacking the ligand binding-domain, the best characterized of which is AR-V7. We have ...

Поиск в электронном архиве

Просмотр

Моя учетная запись